Xencor Inc (XNCR) Insider Trading Disclosures
Xencor Inc (XNCR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: XNCR
CIK: 1326732
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerEmad Fareed
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001326732-26-000056 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001326732-26-000055 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001489 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-29 | 8-K | 0001326732-26-000049 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-06-16 | FORM 4 | 0001758108-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-06-16 | FORM 4 | 0001201096-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-06-16 | FORM 4 | 0001462354-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-06-16 | FORM 4 | 0001647647-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-06-16 | FORM 4 | 0001313936-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-06-16 | FORM 4 | 0001225617-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-06-16 | FORM 4 | 0001216477-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-06-16 | FORM 4 | 0002079360-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | FORM 4 | 0001758108-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-16 | 8-K | 0001326732-26-000045 | View SEC Doc Filr Page |
| 144 | 2026-06-18 | — | 144 Filing | 0001959173-26-004758 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | FORM 4 | 0001201096-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | FORM 4 | 0001462354-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | FORM 4 | 0001225617-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | FORM 4 | 0001313936-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-06-15 | — | 144 Filing | 0001959173-26-004639 | View SEC Doc Filr Page |
| 144 | 2026-06-15 | — | 144 Filing | 0001959173-26-004634 | View SEC Doc Filr Page |
| 144 | 2026-06-15 | — | 144 Filing | 0001959173-26-004632 | View SEC Doc Filr Page |
| 144 | 2026-06-15 | — | 144 Filing | 0001959173-26-004624 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000935836-26-000264 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | 10-Q | 0001326732-26-000043 | View SEC Doc Filr Page |